Elucidation of Selective Apoptosis of Breast Cancer Cells Induced by Panax ginseng-Derived Exosomes via Regulation of Bax/Bcl-2 Ratio and AMPK-α Signaling.
- 1Department of Food Technology & Nutrition Sunmoon University Asan-si Chungcheongnam-do Republic of Korea sunmoon.ac.kr.
Abstract
This study evaluated the anticancer potential of Panax ginseng-derived exosomes (PGEs) against MDA-MB-231 breast cancer cells, focusing on AMP-activated protein kinase (AMPK)-mediated apoptosis and tumor cell selectivity. PGE was isolated using size-exclusion chromatography and exhibited a mean particle size of 163.4 nm with a concentration of 1.2 × 10¹⁰ particles/mL. The exosomal identity was verified by elevated expression levels of CD9 (91.4%), CD63 (96.8%), and TET-8 (127.2%). Treatment with PGE caused a dose-dependent decline in the viability of MDA-MB-231 cells (87.2% at 0.38 × 10¹⁰ particles/mL), while normal human mammary epithelial cells (HMECs) maintained 90.1% viability even at 3.0 × 10¹⁰ particles/mL, indicating selective induction of apoptosis. In scratch assays, PGE suppressed MDA-MB-231 migration by up to 29.8% but enhanced HMEC proliferation and migration by 88.5%, demonstrating selective anti-invasive effects. Molecular analysis showed increased expression of AMPK-α, Bax, caspase-3, and caspase-9, coupled with downregulation of Bcl-2 and vascular endothelial growth factor, thereby validating mitochondrial apoptosis as the underlying mechanism. Flow cytometry further revealed a dose-dependent increase in early and late apoptosis in MDA-MB-231 cells (total apoptosis: 17.7%-32.9%), while HMEC displayed only minimal apoptotic response (< 7.6%). Immunofluorescence analysis also indicated chromatin condensation, ZO-1 disruption, and F-actin reorganization in MDA-MB-231, whereas HMEC preserved structural integrity with enhanced ZO-1 and F-actin intensity. LC-MS/MS profiling identified ginsenosides Rf, Rh1, and Rb1 as principal bioactive constituents of PGE, implicating them in AMPK-dependent apoptosis. Taken together, these results demonstrated that PGE selectively triggers apoptosis in breast cancer cells while maintaining normal cell viability, highlighting its potential as a natural exosome-based anticancer therapeutic with strong biocompatibility and translational potential.
Related
- Brown and white adipocyte like cells derived exosomes differentially regulate stemness, hormone secretion, apoptosis, and lipid metabolism in model cells
- A nanosystem manipulates angiocrine signaling for cardioprotection in male mice by relocalizing endothelial exosomes
- Engineered Brain‐Targeted Exosomes Delivering FGF1 for Sustained Glycemic Regulation and Multitarget Neurovascular Protection in Diabetic Stroke
- Mesenchymal Stem Cell-Derived Exosomes for Bone Regeneration: Modification Strategies and miRNA-Mediated Modulation of Osteogenic Signaling
- PACE4 Regulates Apoptosis in Human Prostate Cancer Cells via Endoplasmic Reticulum Stress and Mitochondrial Signaling Pathways [Retraction].
BibTeX
@article{han2026elucidation,
title = {{Elucidation of Selective Apoptosis of Breast Cancer Cells Induced by Panax ginseng-Derived Exosomes via Regulation of Bax/Bcl-2 Ratio and AMPK-α Signaling.}},
author = {Min Ho Han and Youn Seon Hwang and Jong Hyun Oh and Do Hyeon Jin and Ju Hwan Lee and Jin Woo Kim},
journal = {International journal of breast cancer},
year = {2026},
month = oct,
doi = {10.1155/ijbc/3346672},
url = {https://europepmc.org/article/MED/42924182},
note = {CC BY},
}
RIS
TY - JOUR
TI - Elucidation of Selective Apoptosis of Breast Cancer Cells Induced by Panax ginseng-Derived Exosomes via Regulation of Bax/Bcl-2 Ratio and AMPK-α Signaling.
AU - Min Ho Han
AU - Youn Seon Hwang
AU - Jong Hyun Oh
AU - Do Hyeon Jin
AU - Ju Hwan Lee
AU - Jin Woo Kim
PY - 2026
DA - 2026/10/22
JO - International journal of breast cancer
DO - 10.1155/ijbc/3346672
UR - https://europepmc.org/article/MED/42924182
AB - This study evaluated the anticancer potential of Panax ginseng-derived exosomes (PGEs) against MDA-MB-231 breast cancer cells, focusing on AMP-activated protein kinase (AMPK)-mediated apoptosis and tumor cell selectivity. PGE was isolated using size-exclusion chromatography and exhibited a mean particle size of 163.4 nm with a concentration of 1.2 × 10¹⁰ particles/mL. The exosomal identity was verified by elevated expression levels of CD9 (91.4%), CD63 (96.8%), and TET-8 (127.2%). Treatment with PGE caused a dose-dependent decline in the viability of MDA-MB-231 cells (87.2% at 0.38 × 10¹⁰ particles/mL), while normal human mammary epithelial cells (HMECs) maintained 90.1% viability even at 3.0 × 10¹⁰ particles/mL, indicating selective induction of apoptosis. In scratch assays, PGE suppressed MDA-MB-231 migration by up to 29.8% but enhanced HMEC proliferation and migration by 88.5%, demonstrating selective anti-invasive effects. Molecular analysis showed increased expression of AMPK-α, Bax, caspase-3, and caspase-9, coupled with downregulation of Bcl-2 and vascular endothelial growth factor, thereby validating mitochondrial apoptosis as the underlying mechanism. Flow cytometry further revealed a dose-dependent increase in early and late apoptosis in MDA-MB-231 cells (total apoptosis: 17.7%-32.9%), while HMEC displayed only minimal apoptotic response (< 7.6%). Immunofluorescence analysis also indicated chromatin condensation, ZO-1 disruption, and F-actin reorganization in MDA-MB-231, whereas HMEC preserved structural integrity with enhanced ZO-1 and F-actin intensity. LC-MS/MS profiling identified ginsenosides Rf, Rh1, and Rb1 as principal bioactive constituents of PGE, implicating them in AMPK-dependent apoptosis. Taken together, these results demonstrated that PGE selectively triggers apoptosis in breast cancer cells while maintaining normal cell viability, highlighting its potential as a natural exosome-based anticancer therapeutic with strong biocompatibility and translational potential.
SN - 2090-3170
SN - 2090-3189
ER -